Evidence map›Paper›PMID 32904490›Full record

ArticleBioMed research international2020

Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.

Shoubin Li, Chunhong Yu, Yunxia Zhang, Junjiang Liu, Yi Jia, Fuzhen Sun, Panying Zhang, Jingpo Li, Liuxiong Guo, Helong Xiao and 4 more

Abstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review.Frontiers in cell and developmental biology · 2021
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. The roles and mechanisms of circular RNAs related to mTOR in cancers.Journal of clinical laboratory analysis · 2022
    Review
  7. Review
  8. Review
  9. Review
  10. The roles of E3 ligases in Hepatocellular carcinoma.American journal of cancer research · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shoubin LiDepartment of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050017, China.ORCID https://orcid.org/0000-0002-6873-0523
Chunhong YuDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Yunxia ZhangDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Junjiang LiuDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Yi JiaDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Fuzhen SunDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Panying ZhangDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Jingpo LiDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Liuxiong GuoDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Helong XiaoDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Fei GaoDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Xinna DengDepartment of Urology, Health Examination Center, Obstetrics and Gynecology, and Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Ziqi CaiHebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei 050000, China.
Jianhui CaiDepartment of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050017, China.ORCID https://orcid.org/0000-0001-7704-339X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

cir-ITCH, a well-known tumor-suppressive circular RNA, plays a critical role in different cancers. However, its expression and functional role in prostate cancer (PCa) are unclear. Herein, we explored the potential mechanism and tumor-inhibiting role of cir-ITCH in PCa. Using reverse transcriptase polymerase chain reaction assay, we analyzed the expression of cir-ITCH in PCa and paired adjacent nontumor tissue samples resected during surgical operation, as well as in two cell lines of human PCa (LNCaP and PC-3) and the immortalized normal prostate epithelial cell line (RWPE-1). Cell viability and migration of PCa cell lines were evaluated using CCK-8 and wound-healing assays. Expression of key proteins of the Wnt/

Indexed as

Cell Line, TumorCell SurvivalDisease ProgressionDown-RegulationHumansMaleMicroRNAsNeoplasm InvasivenessPC-3 CellsProstatic Neoplasms, Castration-ResistantReceptors, AndrogenRNA, CircularRNA, UntranslatedWnt Signaling PathwayAR protein, humancir-ITCH noncoding RNA, humanMicroRNAsMIRN17 microRNA, humanReceptors, AndrogenRNA, CircularRNA, Untranslated

Identifiers

PMID32904490
PMCPMC7456474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.